FDA Information - October 7, 2008

FDA Issues Warning On Chinese-Made Infant Formula

September 12, 2008 - Topics fda, infant, nutrition, pets and babies
The U.S. Food and Drug Administration (FDA) has issued a warning about buying any infant formula imported from China, after a brand called Sanlu was linked with kidney stones in infants.

Federal authorities have especially warned Chinese American communities across the United States, including Southern California, which houses the largest ethnic Chinese populations in the nation

read more >>

FDA Panel Says Benefits Of Pfizer Osteoporosis Drug Fablyn Outweigh Risks

September 9, 2008 - Topics osteoporosis, fda, women, pharmaceutical and blood
Pfizer Inc.'s proposed osteoporosis drug could be useful for postmenopausal women and the benefits outweigh risks such as blood clots, an expert advisory panel said on Monday.

However, the drug, Fablyn (lasofoxifene tartrate) should be restricted to women at high risk of fracture or those who fail other treatments

read more >>

Hershey's Issues A Nationwide Recall For Chocolate Product

September 6, 2008 - Topics chocolate, allergy and fda
The Hershey Company is recalling 7.25-ounce plastic bottles of Hershey's Chocolate Shell Topping because it contains almonds that aren't noted on the label.

Grocery store chain Stop & Shop Supermarket Co. on Friday alerted its customers of the voluntary recall by the Hershey's Chocolate Shell Topping that can be poured over ice cream

read more >>

Hearshey's Issues A Nationwide Recall For Chocolate Product

September 5, 2008 - Topics chocolate, fda and allergy
The Hershey Company is recalling 7.25-ounce plastic bottles of Hershey's Chocolate Shell Topping because it contains almonds that aren't noted on the label.

Grocery store chain Stop & Shop Supermarket Co. on Friday alerted its customers of the voluntary recall by the Hershey's Chocolate Shell Topping that can be poured over ice cream

read more >>

FDA To Evaluate 20 Drugs For Potential Side Effects

September 5, 2008 - Topics fda, cancer, cymbalta, safety and food
The U.S. Food and Drug Administration (FDA) released its first quarterly report listing certain drugs that are being evaluated for potential side effects.

The drugs, 20 in total, have been identified based on a review of reports in FDA's Adverse Event Reporting System (AERS), which contains millions of reports of adverse events submitted to the FDA by drug manufacturers, health care professionals and patients

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use